血液净化对肾综合征出血热炎症介质的清除作用

目的　通过观察连续性肾替代治疗 (CRRT)对肾病综合征出血热 (HFRS)患者肿瘤坏死因子α(TNF α)、白介素 6(IL 6 )及内皮素 1(ET 1)的清除作用 ,探讨炎症介质在HFRS中的作用。方法　将诊断为HFRS的中型及以上类型患者 4 0例随机分为两组 :CVVH组 2 0例行CVVH ,HD组 2 0例行HD。用ELISA法检测TNF α和IL 6浓度 ,放射免疫法测定ET 1浓度。结果　①CVVH组及HD组少尿天数 (3.0± 2 .1,6 .0± 3.4 )、并发症发生率 (2 5 % ,4 0 % )及病死率 (15 % ,2 5 % )差异均有显著性 (P <0 .0 1)。②两组治疗前后血肌酐和尿素氮下降有显著性差异 (P <0 .0 1)。③CVVH组治疗后血中TNF α、IL 6和ET 1均较治疗前明显降低 ,差异均有显著性意义 (P均 <0 .0 1) ;HD组治疗前后血中TNF α、IL 6和ET 1无显著性差异 (P >0 .0 5 )。④CVVH组滤出液中可持续检测到IL 6及ET 1,未检测到TNF α。透出液中未检测到上述炎症介质。结论　连续性血液净化治疗可清除炎症介质 ,改善HFRS的病理生理过程 ,改善肾功能和预后 ,减少并发症 ,降低病死率 ,是治疗HFRS的最佳方法

The effect of blood purification on removing plasma inflammatory mediators in HFRS patients

Objective To observe the removal of tumor necrosis factor-α (TNF-α ), interleukin-6 (IL-6) and endothelin-1 (ET-1) in continuous renal replacement therapy (CRRT) on hemorrhagic fever with renal syndrome (HFRS) patients, and investigate the effect of inflammatory mediators on HFRS. Methods A total of 40 patients with moderate or more severe HFRS were divided into two groups randomly. Continuous venous-venous hemofiltration (CVVH) was applied to the 20 cases in CVVH group, and hemodialysis (HD) was applied to the 20 cases in HD group. The levels of TNF-α and IL-6 were measured by enzyme-linked immunosorbent assay (ELISA), and ET-1 level was measured by radioimmunoassays (RIA). Results ① In comparing CVVH and HD groups, the days of oliguria (3.0±2.1, 6.0±3.4), incidence of complications (25%, 40%), and mortality (15%, 25%) had significant differences (P<0.01). ② The decrease of plasma BUN and Cr had significant differences before and after treatment in both CVVH and HD groups (P<0.01). ③ In CVVH group, the plasma levels of TNF-α, IL-6 and ET-1 decreased markedly after treatment in comparison with those before treatment, with significant differences (P<0.05). In contrast, the levels of TNF-α, IL-6 and ET-1 in HD group did not significantly differ before and after treatment (P>0.05). ④ In CVVH group, IL-6 and ET-1 could be detected constantly in filtrate, but TNF-α was not detectable. TNF-α, IL-6 and ET-1 were not detectable in dialysate. Conclusion Continuous blood purification can remove plasma inflammatory mediators. Therefore, it is helpful in recovering renal function, improving the prognosis of HFRS, and decreasing complications and mortality. CVVH is one of the best methods to treat HFRS.